|
Mr. Simon has been a Managing Director of Clarus Ventures LLC a life sciences focused venture capital firm that he co-founded in 2005. He has been a General Partner of MPM BioVentures III since October 2001. He has more than 26 years of industry and investment experience in biotechnology. From 1989 to 2000 Mr. Simon served in various management positions at Genentech Inc. including Vice President of Business and Corporate Development. Mr. Simon currently serves on the Board of Directors of ARYx Therapeutics (ARYX) and Poniard Inc. (PARD) both publicly traded companies and also Neosil Inc. Pearl Therapeutics QuatRx Pharmaceuticals Sientra Inc. and Verus Pharmaceuticals Inc. which are private biotech companies. Mr. Simon is also on the Advisory Council at the Gladstone Institute a private not-for-profit research institute affiliated with the University of California San Francisco . Mr. Simon received a B.S. degree in microbiology from the University of Maryland and a M.B.A in marketing from Loyola University. | 